Oramed Pharmaceuticals Fundamental Relationships

ORMP -- Israel Stock  

null 1,732  108.00  5.87%

The Drivers Module shows relationships between Oramed Pharmaceuticals's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of Oramed Pharmaceuticals over time as well as its relative position and ranking within its peers. Additionally take a look at Your Equity Center.

Oramed Pharmaceuticals Market Capitalization vs. EBITDA Fundamental Analysis

Oramed Pharmaceuticals is rated below average in ebitda category among related companies. It is rated below average in market capitalization category among related companies .
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Oramed Pharmaceuticals 
Basic Expenses 
(13.22 M)
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Market Capitalization is total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Oramed Pharmaceuticals 
Market Cap 
Shares Outstanding 
Share Price 
290.34 M
In most publications or references market cap is broken down into the mega cap, large cap, mid cap, small cap, micro cap, and nano cap. Market Cap is a measurement of business as total market value of all of outstanding shares at a given time, and can be used to compare different companies based on their size.
      Oramed Pharmaceuticals Comparables 
Oramed Pharmaceuticals is currently under evaluation in revenue category among related companies.
Search macroaxis.com